Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2014 Volume 8 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2014 Volume 8 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy

  • Authors:
    • Yan‑Shan Chen
    • Ling Shen
    • Rui‑Qin Mai
    • Ying Wang
  • View Affiliations / Copyright

    Affiliations: Department of Gynecology and Obstetrics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China, Department of Clinical Laboratory, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, P.R. China
  • Pages: 1523-1527
    |
    Published online on: September 2, 2014
       https://doi.org/10.3892/etm.2014.1946
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to explore the association between the expression of microRNA (miRNA)‑181b and plasminogen activator inhibitor‑1 (PAI‑1) in the placental tissue of pregnant females with a hypertensive disorder complicating pregnancy (HDCP). Placental tissue samples were obtained from 48 patients with HDCP and 40 females with a normal pregnancy. The levels of miRNA‑181b and PAI‑1 mRNA were determined by the reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The expression of PAI‑1 protein was analyzed by western blotting. Vascular smooth muscle cells (VSMCs) were transfected with the pEGP‑miRNA‑181b plasmid using Lipofectamine® 2000. Transfection efficiency was confirmed by immunohistochemical analysis. The levels of miRNA‑181b in the placental tissue of patients with HDCP were lower than those in the control group, whereas the levels of PAI‑1 mRNA in the placental tissue of patients with HDCP were higher than those in the control group. The expression of the PAI‑1 protein in the HDCP group was higher than that in the control group. Following transfection of VSMCs with plasmid pGCMV/EGFP/miRNA‑181b, the levels of PAI‑1 mRNA were reduced while the levels of miRNA‑181 were upregulated. Furthermore, the expression levels of PAI‑1 protein were lower than those in the control group. The levels of miRNA‑181b and PAI‑1 mRNA were strongly associated with HDCP. Thus, miRNA‑181b may play an important role in the regulation of PAI‑1. PAI‑1 and miRNA‑181b may be novel biomarkers to be used in HDCP therapy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Zhou J, Xiao XM and Wu YH: Expression of interferon-γ in decidual natural killer cells from women with hypertensive disorder complicating pregnancy. J Obstet Gynaecol Res. 40:670–676. 2014.

2 

Yang L, Wang YL, Liu S, et al: miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells. FEBS Lett. 588:124–130. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Shi L, Cheng Z, Zhang J, et al: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236:185–193. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Simone TM, Archambeault J and Higgins PJ: Small molecule targeting of PAI-1 function: a new therapeutic approach for treatment of vascular stenosis. J Mol Genet Med. 7:10000592013. View Article : Google Scholar : PubMed/NCBI

5 

Gomes-Giacoia E, Miyake M, Goodison S and Rosser CJ: Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol Cancer Ther. 12:2697–2708. 2013. View Article : Google Scholar

6 

Boe AE, Eren M, Murphy SB, et al: Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation. 128:2318–2324. 2013.PubMed/NCBI

7 

Li LX, Liu YL, Wen JG, et al: Expression and significance of aquaporin 1 in placenta, placental membranes and peritoneum of patients with hypertensive disorder complicating pregnancy. Zhonghua Fu Chan Ke Za Zhi. 43:497–501. 2008.(In Chinese).

8 

Salmani D, Purushothaman S, Somashekara SC, et al: Study of structural changes in placenta in pregnancy-induced hypertension. J Nat Sci Biol Med. 5:352–355. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Okawara M, Seki H, Matsuoka K, et al: Examination of the expression of cyclooxygenase-2 in placenta villi from sufferers of pregnancy induced hypertension. Biol Pharm Bull. 32:2053–2056. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Henao-Mejia J, Williams A, Goff LA, et al: The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity. 38:984–997. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Zhu Y, Wu J, Li S, et al: The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Cell Physiol Biochem. 32:1225–1237. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Zhai XF, Fang FF, Liu Q, et al: MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells. BMC Complement Altern Med. 13:3252013. View Article : Google Scholar : PubMed/NCBI

13 

Wang XF, Shi ZM, Wang XR, et al: MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer Res Clin Oncol. 138:573–584. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Kronski E, Fiori ME, Barbieri O, et al: miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol. 8:581–595. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Yan JJ, Zhu XM, Yin GW, et al: Effect of human miR-181a on function of trophoblast cell line HTR-8/SVneo. Zhonghua Lin Chuang Yi Shi Za Zhi (Dian Zi Ban). 7:136–138. 2013.(In Chinese).

16 

Simone TM and Higgins PJ: Low molecular weight antagonists of plasminogen activator inhibitor-1: therapeutic potential in cardiovascular disease. Mol Med Ther. 1:1012012. View Article : Google Scholar : PubMed/NCBI

17 

Yang Z, Wan X, Gu Z, et al: Evolution of the mir-181 microRNA family. Comput Biol Med. 52:82–87. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Madonna R and De Caterina R: Cellular and molecular mechanisms of vascular injury in diabetes - part I: pathways of vascular disease in diabetes. Vascul Pharmacol. 54:68–74. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Cawyer RC, Horvat D, Leonard D, et al: Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol. May 1–2014.(Epub ahead of print).

20 

Su L, Liu R, Cheng W, et al: Expression patterns of microRNAs in porcine endometrium and their potential roles in embryo implantation and placentation. PLoS One. 9:e878672014. View Article : Google Scholar : PubMed/NCBI

21 

Estella C, Herrer I, Moreno-Moya JM, et al: miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One. 7:e410802012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen YS, Shen L, Mai RQ and Wang Y: Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy . Exp Ther Med 8: 1523-1527, 2014.
APA
Chen, Y., Shen, L., Mai, R., & Wang, Y. (2014). Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy . Experimental and Therapeutic Medicine, 8, 1523-1527. https://doi.org/10.3892/etm.2014.1946
MLA
Chen, Y., Shen, L., Mai, R., Wang, Y."Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy ". Experimental and Therapeutic Medicine 8.5 (2014): 1523-1527.
Chicago
Chen, Y., Shen, L., Mai, R., Wang, Y."Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy ". Experimental and Therapeutic Medicine 8, no. 5 (2014): 1523-1527. https://doi.org/10.3892/etm.2014.1946
Copy and paste a formatted citation
x
Spandidos Publications style
Chen YS, Shen L, Mai RQ and Wang Y: Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy . Exp Ther Med 8: 1523-1527, 2014.
APA
Chen, Y., Shen, L., Mai, R., & Wang, Y. (2014). Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy . Experimental and Therapeutic Medicine, 8, 1523-1527. https://doi.org/10.3892/etm.2014.1946
MLA
Chen, Y., Shen, L., Mai, R., Wang, Y."Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy ". Experimental and Therapeutic Medicine 8.5 (2014): 1523-1527.
Chicago
Chen, Y., Shen, L., Mai, R., Wang, Y."Levels of microRNA‑181b and plasminogen activator inhibitor‑1 are associated with hypertensive disorders complicating pregnancy ". Experimental and Therapeutic Medicine 8, no. 5 (2014): 1523-1527. https://doi.org/10.3892/etm.2014.1946
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team